🟢 Harrow Health is trading 5% up in pre-market

Harrow Health is trading at $27.40, up 5.22% in pre-market, with no clear company-specific explanation identified for the November 6 move.

• Harrow Health fell 9.43% on November 5; its next scheduled earnings report is November 9.
• Technology futures were rebounding after the prior session’s selloff, while healthcare-sector pre-market context was negative.